The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma

Autor: Veronique Cocquyt, G. Bries, Nicole Straetmans, Laetitia Gerlier, C. Focan, D. Verhoeven, Jeroen Mebis, Ahmad Awada, Mark Lamotte, Yassine Lalami, André Bosly, Luc Somers, Stéphanie Henry, Jean-Pascal Machiels
Přispěvatelé: UCL - (MGD) Service d'oncologie médicale, UCL - (MGD) Service d'hématologie, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (SLuc) Unité d'oncologie médicale
Jazyk: angličtina
Rok vydání: 2010
Předmět:
Male
Cancer Research
Time Factors
medicine.medical_treatment
Neutropenia - chemically induced
epidemiology
prevention & control
Physician's Practice Patterns
Breast Neoplasms -- drug therapy -- epidemiology
CHOP
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
RECOMMENDATIONS
Belgium
QUALITY-OF-LIFE
Antineoplastic Combined Chemotherapy Protocols
Granulocyte Colony-Stimulating Factor
Medicine and Health Sciences
Practice Patterns
Physicians'
GROWTH-FACTORS
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Academic Medical Centers
Lymphoma
Non-Hodgkin
Incidence (epidemiology)
Incidence
Fever - chemically induced
epidemiology
prevention & control
Middle Aged
COLONY-STIMULATING FACTOR
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Hospitalization
Lymphoma
Non-Hodgkin -- drug therapy -- epidemiology
Belgium - epidemiology
Treatment Outcome
Oncology
Docetaxel
Practice Guidelines as Topic
Female
Guideline Adherence
OBSERVATIONAL EUROPEAN NEUTROPENIA
Research Article
medicine.drug
Adult
medicine.medical_specialty
Neutropenia
Fever
Neutropenia -- chemically induced -- epidemiology -- prevention & control
Breast Neoplasms
Hospitals
General
lcsh:RC254-282
Young Adult
Breast cancer
Internal medicine
Genetics
medicine
Belgium -- epidemiology
Humans
Intensive care medicine
Breast Neoplasms - drug therapy
epidemiology
Granulocyte Colony-Stimulating Factor -- therapeutic use
Fever -- chemically induced -- epidemiology -- prevention & control
Aged
Retrospective Studies
Chemotherapy
business.industry
MORTALITY
DOSE INTENSITY
PATIENTS RECEIVING CHEMOTHERAPY
medicine.disease
Non-Hodgkin's lymphoma
Cancérologie
CLINICAL-PRACTICE
Health Care Surveys
Lymphoma
Non-Hodgkin - drug therapy
epidemiology
business
Granulocyte Colony-Stimulating Factor - therapeutic use
Febrile neutropenia
Zdroj: BMC CANCER
BMC Cancer, Vol 10, Iss 1, p 642 (2010)
BMC cancer, 10
BMC Cancer, Vol. 10, p. 642 [1-10] (2010)
BMC Cancer
ISSN: 1471-2407
Popis: The use of chemotherapy regimens with moderate or high risk of febrile neutropenia (defined as having a FN incidence of 10% or more) and the respective incidence and clinical management of FN in breast cancer and NHL has not been studied in Belgium. The existence of a medical need for G-CSF primary and secondary prophylaxis with these regimens was investigated in a real-life setting.
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
info:eu-repo/semantics/published
Databáze: OpenAIRE
Externí odkaz: